14 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
;
manufacturing and product quality issues related to scale-up of manufacturing;
costs and validation of new equipment and facilities required
S-4/A
l3exd qntcdv
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
30yj03codhmom29ef4w
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-10.1
t4c1 kkkeugk2x
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
r8rpai1zs4
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-1.1
wkw7ix0yyhxx9cvsp5x
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
F-1/A
EX-10.8
9u938phq3qjnv
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.12
w239ixnd861zhdymkg
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.7
qp42l9twfama3xh ser
18 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next